This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Referral criteria from primary care - benign prostatic hyperplasia

Authoring team

Specialist referral should be considered for

  • patients with severe symptoms particularly when rapidly progressive

  • where rectal examination is abnormal

  • in complicated BPH e.g. recurrent urinary infections, haematuria, urinary retention, obstructive nephropathy, bladder stones

  • patients with raised PSA

  • patients who fail to respond to drug treatment for BPH

Consider urgent referral guidance re: prostate cancer (2)

  • refer men using a suspected cancer pathway referral (for an appointment within 2 weeks) for prostate cancer if their prostate feels malignant on digital rectal examination

  • consider a prostate-specific antigen (PSA) test and digital rectal examination to assess for prostate cancer in men with:
    • any lower urinary tract symptoms, such as nocturia, urinary frequency, hesitancy, urgency or
    • retention or
    • erectile dysfunction or
    • visible haematuria

  • refer men using a suspected cancer pathway referral (for an appointment within 2 weeks) for prostate cancer if their PSA levels are above the age-specific reference range

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.